Moderna (MRNA.O) pre-market US shares jumped over 100% after the company and
Merck (MRK.O) said their melanoma vaccine met the primary endpoint in a large
trial.
2026-08-19
Moderna (MRNA.O) pre-market US shares jumped over 100% after the company and
Merck (MRK.O) said their melanoma vaccine met the primary endpoint in a large
trial.